Member Info for mazik

Bc201 and val 301 update will be icing of the cake...

Valirx intends to share these results with potential industry partners to evaluate all options for further clinical development of VAL201. This is what we are waiting for, 62 million shares with Mcap under £17 million, on success of VAL201 Phase 2.. we will be towards mcap of well over £50 million..IMO

Bullsh*t...£..no chance..pence maybe..taka after getting mugged

Taking to the Toilet... Omg peeps were buying for 20p ...shameful..

Down by 40% in a day... glad did not buy on yesterday's spike :-)

This should be multibagger in the making .
We are on track to produce our first precious metals from the spoil heaps at Mineral Jackpot and to prove our concept. Until the recent completion of laboratory testing, we could not be sure that gravity separation would be a viable option for producing gold and silver from Mineral Jackpot, but I am now pleased to report that we believe it is. In the immediate term, therefore, we expect to produce gold and silver through gravity separation while for the longer term we will develop an optimised leaching facility, based on the data acquired from the ongoing extensive testing programme, to achieve a higher long-term recovery rate. Under £7 million market Cap under million oz of gold adds more towards £50 million..IMO

Well topup time 15,849 showing on the sales column, either the software has animoly or mm are drunk :-)

BlackIsleboy,
Grant application has been submitted to IRR, according to the RNS it should be concluded by the end of October..thats not the only reason we are here. :-)

Icemam thank u , respect ! I agree with u...potential here is enormous :-)

Expecting update on bc201 and val301, am I too eager..lol...this is well oversold from heights of 65p to 24p....charts all pointing towards north of 30p plus, reminder only 62 million shares...

lovesingh1 agree, agree this is well oversold..IMO

mornington-oz
I agree with u, with too much news we have " A grant application has been submitted to UK Research and Innovation (UKRI) to fund preliminary laboratory studies investigating the potential of Sareum's TYK2/JAK1 inhibitors to address the severe inflammatory responses (the "cytokine storm") and potentially fatal respiratory symptoms of Covid-19 and other viral infections."

Blue this afternnon, demand will overtake..

Rerate to continue "Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the "cytokine storm" immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).
The Company's preclinical FLT3+Aurora inhibitor programme targeting haematological cancers is licensed to a China-based specialty pharma company.
Sareum also has an economic interest in SRA737, a clinical-stage oral, selective Checkpoint kinase 1 (Chk1) inhibitor that targets cancer cell replication and DNA damage repair mechanisms. Preliminary Phase 2 and comprehensive preclinical data suggest SRA737 may have broad application in combination with other oncology and immune-oncology drugs in genetically defined patients.
SRA737 was discovered and initially developed by scientists at The Institute of Cancer Research in collaboration with Sareum, and with funding from Sareum and Cancer Research UK. SRA737 was licensed by CRT Pioneer Fund (CPF) to Sierra Oncology Inc. Sierra is currently exploring options to obtain the funding or support necessary to advance the future development of SRA737. Holding tight until 10p, future is very bright..IMO

Good Morning Brighty " Board and management will continue to employ rigorous capital management in the development of its internal assets and its overall business, with a clear focus on generating value for shareholders."
Hold tight for 500% appreciation...by end of this month..

Excellent RNS " Board and management will continue to employ rigorous capital management in the development of its internal assets and its overall business, with a clear focus on generating value for shareholders."

$11.90 firm on Naz

Like many anticipate 5p sooner than we expect on news by end of this week IMO.

The rerate is moving faster than one can press the key to buy :-)

U are missing 500% by end of this week, no patience...amazed they cannot hold for more than couple of hours